Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments (2021 - 2026)

Praxis Precision Medicines' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $142.6 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 116.04% year-over-year to $142.6 million in Q1 2026; TTM through Mar 2026 was $389.3 million, a 105.96% increase from a year earlier, with the FY2025 full-year figure at $312.7 million, up 154.19% from the prior year.
• Change in Acquisitions & Divestments rose to $142.6 million in Q1 2026 per PRAX's latest filing, from $61.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $142.6 million in Q1 2026 and bottomed at $3.0 million in Q2 2024.
• The 5-year median for Change in Acquisitions & Divestments is $58.9 million (2024), against an average of $57.0 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 85.71% in 2023 and surged 1876.57% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $22.6 million in 2022, then plunged by 77.87% to $5.0 million in 2023, then surged by 1070.0% to $58.5 million in 2024, then grew by 5.78% to $61.9 million in 2025, then soared by 130.38% to $142.6 million in 2026.
• Per Business Quant, the three latest PRAX Change in Acquisitions & Divestments figures stand at $142.6 million (Q1 2026), $61.9 million (Q4 2025), and $125.5 million (Q3 2025).